Dr. Elan Cohen, PhD
Claim this profileHassman Research Institute
Studies Schizophrenia
Studies Depression
6 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Elan Cohen, PhD is currently running
Emraclidine
for Schizophrenia
This trial is testing a new medication called Emraclidine, given in two different doses daily. It aims to help people with schizophrenia who are having severe symptom flare-ups. The medication works by targeting specific parts of the brain to reduce symptoms like hallucinations and delusions.
Recruiting0 awards Phase 26 criteria
LB-102
for Schizophrenia
This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center inpatient study to evaluate the efficacy and safety of LB-102 in adult patients diagnosed with acutely exacerbated schizophrenia. To determine whether LB-102 administered to patients with acutely exacerbated schizophrenia demonstrates antipsychotic efficacy, as determined by a change from Baseline on the Positive and Negative Syndrome Scale (PANSS) total score, compared to placebo at 28 days. The secondary objectives of the study are to evaluate improvement in CGI-S, safety and tolerability, and pharmacokinetics.
Recruiting0 awards Phase 2
More about Elan Cohen, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Elan Cohen, PhD has experience with
- BI 1358894
- Quetiapine
- Placebo
- Not Applicable
- Pregabalin 300mg
- Pregabalin 450 Mg
Breakdown of trials Elan Cohen, PhD has run
Schizophrenia
Depression
Major Depressive Disorder
Substance Abuse
Healthy Subjects
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elan Cohen, PhD specialize in?
Elan Cohen, PhD focuses on Schizophrenia and Depression. In particular, much of their work with Schizophrenia has involved treating patients, or patients who are undergoing treatment.
Is Elan Cohen, PhD currently recruiting for clinical trials?
Yes, Elan Cohen, PhD is currently recruiting for 2 clinical trials in Berlin New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Elan Cohen, PhD has studied deeply?
Yes, Elan Cohen, PhD has studied treatments such as BI 1358894, Quetiapine, Placebo.
What is the best way to schedule an appointment with Elan Cohen, PhD?
Apply for one of the trials that Elan Cohen, PhD is conducting.
What is the office address of Elan Cohen, PhD?
The office of Elan Cohen, PhD is located at: Hassman Research Institute, Berlin, New Jersey 08009 United States. This is the address for their practice at the Hassman Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.